Efficacy and safety of lamivudine for treatment of chronic hepatitis B in renal allograft recipients

By Alavian S.M.   Hajarizadeh B.   Einollahi B.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2687-2688

Elsevier

Access to resources Recommend Favorite

Lamivudine therapy in renal allograft recipients with hepatitis B virus infection

By Tsang W.K.   Tong K.L.   Chan H.W.H.  

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 278-279

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of lamivudine in renal transplant patients with chronic hepatitis B

By Antoine C.   Landau A.   Menoyo V.   Duong J.P.   Duboust A.   Glotz D.  

Transplantation Proceedings, Vol. 32, Iss. 2, 2000-03 ,pp. : 384-385

Elsevier

Access to resources Recommend Favorite

Lamivudine in renal transplant candidates with chronic hepatitis B infection

By Boyacioglu S.   Gur G.   Gursoy M.   Ozdemir N.  

Transplantation Proceedings, Vol. 34, Iss. 6, 2002-09 ,pp. : 2131-2132

Elsevier

Access to resources Recommend Favorite

Use of combined treatment of hepatitis B immune globulin and lamivudine as prevention of hepatitis B virus recurrence in liver allograft

By Albeniz Arbizu E.   Barcena Marugan R.   Oton Nieto E.   Mateo Lindeman M.   Garcia Gonzalez M.   de Vicente Lopez E.   Moraleda Garcia G.  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1844-1845

Elsevier

Access to resources Recommend Favorite